Cheng-Hsiu Lin
5Patents
0h-index
6Co-inventors
27Inventor score
Filing activity: Jul 15, 2015 → May 5, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10449223B2 | Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia | Human Necessities | 0 | Active |
| US9877980B2 | Method and composition for treatment or prevention of type 2 diabetes and hyperlipidemia | Human Necessities | 0 | Active |
| US9757393B2 | Derivatives of ergostatrien-3-β-ol from antrodia camphorata and antiglycemic, antihyperlipidemic and decreasing hepatic fat use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9844543B2 | Method of treating or preventing hyperlipidemia with caffeamide derivatives | Human Necessities | 0 | Active |
| US10124012B2 | Method for treatment of hyperglycemia and hyperlipidemia | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.